Effect of mild or moderate hepatic impairment on the pharmacokinetics of risdiplam.

Authors:
Kletzl H; Ajmi H; Antys I; Heinig K; Jaber B and 3 more

Journal:
Br J Clin Pharmacol

Publication Year: 2022

DOI:
10.1111/bcp.15319

PMCID:
PMC9546347

PMID:
35301746

Journal Information

Full Title: Br J Clin Pharmacol

Abbreviation: Br J Clin Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST H.K., K.H., B.J. and A.Y. are current employees of and hold shares in F. Hoffmann‐La Roche Ltd. H.A. and I.A. have no conflicts of interest to declare. T.M. is an employee and equity owner of the Orlando Clinical Research Center. A.G. is a current employee of F. Hoffmann‐La Roche Ltd."

Evidence found in paper:

"Funding information F. Hoffmann‐La Roche Ltd"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025